doc.ai is a digital health company designed for a new generation of medical research.
doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building. The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 7, 2017 | Series Unknown | — | 1 | Pantera Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Pantera Capital | Yes | Series Unknown |